Martingale Asset Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16,827	Closed	-$131K	–	843
2021 Q1	$131K	Buy	+16,827	New	+$131K	﹤0.01%	830
2020 Q4	–	Sell	-99,423	Closed	-$662K	–	914
2020 Q3	$662K	Sell	99,423 -33,193	-25%	-$221K	0.01%	744
2020 Q2	$1.11M	Buy	+132,616	New	+$1.11M	0.01%	709